Human Immunodeficiency Virus Rapid Test Kits Market Size 2024-2028
The human immunodeficiency virus (HIV) rapid test kits market size is forecast to increase by USD 294.96 million at a CAGR of 6.52% between 2023 and 2028. The market is experiencing significant growth due to several key trends. The rise in awareness programs for HIV testing is a major driver, as more individuals are becoming conscious of the importance of early detection and treatment. Additionally, efforts to increase pre-marital screenings for HIV are gaining momentum, particularly in regions with high HIV prevalence rates. However, challenges remain, including the non-availability of rapid HIV products in limited-resource settings, which hampers widespread testing and diagnosis. Despite these challenges, advancements in technology and increasing government initiatives to improve access to HIV testing are expected to fuel market growth.
_Rapid_Test_Kits_Market_size_abstract_2024_v1.jpg.webp?v4.1.20)
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global human immunodeficiency virus (HIV) rapid test kits market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global human immunodeficiency virus (hiv) rapid test kits market 2018 - 2022 ($ million)
- 4.2 End-user Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – End-user Segment 2018 - 2022 ($ million)
- 4.3 Type Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Type Segment 2018 - 2022 ($ million)
- 4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)
- 4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
- 6.1 Market segments
- Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
- Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
- 6.2 Comparison by End-user
- Exhibit 32: Chart on Comparison by End-user
- Exhibit 33: Data Table on Comparison by End-user
- 6.3 Diagnostic centers - Market size and forecast 2023-2028
- Exhibit 34: Chart on Diagnostic centers - Market size and forecast 2023-2028 ($ million)
- Exhibit 35: Data Table on Diagnostic centers - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Chart on Diagnostic centers - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Diagnostic centers - Year-over-year growth 2023-2028 (%)
- 6.4 Hospitals and clinics - Market size and forecast 2023-2028
- Exhibit 38: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
- Exhibit 39: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
- 6.5 Market opportunity by End-user
- Exhibit 42: Market opportunity by End-user ($ million)
- Exhibit 43: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Type
- 7.1 Market segments
- Exhibit 44: Chart on Type - Market share 2023-2028 (%)
- Exhibit 45: Data Table on Type - Market share 2023-2028 (%)
- 7.2 Comparison by Type
- Exhibit 46: Chart on Comparison by Type
- Exhibit 47: Data Table on Comparison by Type
- 7.3 HIV rapid immunoassay test - Market size and forecast 2023-2028
- Exhibit 48: Chart on HIV rapid immunoassay test - Market size and forecast 2023-2028 ($ million)
- Exhibit 49: Data Table on HIV rapid immunoassay test - Market size and forecast 2023-2028 ($ million)
- Exhibit 50: Chart on HIV rapid immunoassay test - Year-over-year growth 2023-2028 (%)
- Exhibit 51: Data Table on HIV rapid immunoassay test - Year-over-year growth 2023-2028 (%)
- 7.4 HIV rapid molecular diagnostic test - Market size and forecast 2023-2028
- Exhibit 52: Chart on HIV rapid molecular diagnostic test - Market size and forecast 2023-2028 ($ million)
- Exhibit 53: Data Table on HIV rapid molecular diagnostic test - Market size and forecast 2023-2028 ($ million)
- Exhibit 54: Chart on HIV rapid molecular diagnostic test - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on HIV rapid molecular diagnostic test - Year-over-year growth 2023-2028 (%)
- 7.5 Market opportunity by Type
- Exhibit 56: Market opportunity by Type ($ million)
- Exhibit 57: Data Table on Market opportunity by Type ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 59: Chart on Market share by geography 2023-2028 (%)
- Exhibit 60: Data Table on Market share by geography 2023-2028 (%)
- 9.2 Geographic comparison
- Exhibit 61: Chart on Geographic comparison
- Exhibit 62: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 UK - Market size and forecast 2023-2028
- Exhibit 83: Chart on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on UK - Year-over-year growth 2023-2028 (%)
- 9.9 China - Market size and forecast 2023-2028
- Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
- 9.10 Germany - Market size and forecast 2023-2028
- Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 9.11 Canada - Market size and forecast 2023-2028
- Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity by geography
- Exhibit 99: Market opportunity by geography ($ million)
- Exhibit 100: Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
- 10.3 Impact of drivers and challenges
- Exhibit 101: Impact of drivers and challenges in 2023 and 2028
11 Vendor Landscape
- 11.2 Vendor landscape
- Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 103: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 104: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 105: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 106: Matrix on vendor position and classification
- 12.3 Abbott Laboratories
- Exhibit 107: Abbott Laboratories - Overview
- Exhibit 108: Abbott Laboratories - Business segments
- Exhibit 109: Abbott Laboratories - Key news
- Exhibit 110: Abbott Laboratories - Key offerings
- Exhibit 111: Abbott Laboratories - Segment focus
- 12.4 AccuQuik Test Kits
- Exhibit 112: AccuQuik Test Kits - Overview
- Exhibit 113: AccuQuik Test Kits - Product / Service
- Exhibit 114: AccuQuik Test Kits - Key offerings
- 12.5 Becton Dickinson and Co.
- Exhibit 115: Becton Dickinson and Co. - Overview
- Exhibit 116: Becton Dickinson and Co. - Business segments
- Exhibit 117: Becton Dickinson and Co. - Key news
- Exhibit 118: Becton Dickinson and Co. - Key offerings
- Exhibit 119: Becton Dickinson and Co. - Segment focus
- 12.6 bioLytical Laboratories Inc.
- Exhibit 120: bioLytical Laboratories Inc. - Overview
- Exhibit 121: bioLytical Laboratories Inc. - Product / Service
- Exhibit 122: bioLytical Laboratories Inc. - Key offerings
- 12.7 bioMerieux SA
- Exhibit 123: bioMerieux SA - Overview
- Exhibit 124: bioMerieux SA - Product / Service
- Exhibit 125: bioMerieux SA - Key news
- Exhibit 126: bioMerieux SA - Key offerings
- 12.8 Chembio Diagnostics Inc.
- Exhibit 127: Chembio Diagnostics Inc. - Overview
- Exhibit 128: Chembio Diagnostics Inc. - Product / Service
- Exhibit 129: Chembio Diagnostics Inc. - Key offerings
- 12.9 Danaher Corp.
- Exhibit 130: Danaher Corp. - Overview
- Exhibit 131: Danaher Corp. - Business segments
- Exhibit 132: Danaher Corp. - Key news
- Exhibit 133: Danaher Corp. - Key offerings
- Exhibit 134: Danaher Corp. - Segment focus
- 12.10 DrSafeHands
- Exhibit 135: DrSafeHands - Overview
- Exhibit 136: DrSafeHands - Product / Service
- Exhibit 137: DrSafeHands - Key offerings
- 12.11 F. Hoffmann La Roche Ltd.
- Exhibit 138: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 139: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 140: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 141: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 142: F. Hoffmann La Roche Ltd. - Segment focus
- 12.12 Fujirebio Holdings Inc.
- Exhibit 143: Fujirebio Holdings Inc. - Overview
- Exhibit 144: Fujirebio Holdings Inc. - Product / Service
- Exhibit 145: Fujirebio Holdings Inc. - Key offerings
- 12.13 Healgen Scientific, LLC
- Exhibit 146: Healgen Scientific, LLC - Overview
- Exhibit 147: Healgen Scientific, LLC - Product / Service
- Exhibit 148: Healgen Scientific, LLC - Key offerings
- 12.14 Hologic Inc.
- Exhibit 149: Hologic Inc. - Overview
- Exhibit 150: Hologic Inc. - Business segments
- Exhibit 151: Hologic Inc. - Key news
- Exhibit 152: Hologic Inc. - Key offerings
- Exhibit 153: Hologic Inc. - Segment focus
- 12.15 J. Mitra and Co. Pvt. Ltd.
- Exhibit 154: J. Mitra and Co. Pvt. Ltd. - Overview
- Exhibit 155: J. Mitra and Co. Pvt. Ltd. - Product / Service
- Exhibit 156: J. Mitra and Co. Pvt. Ltd. - Key offerings
- 12.16 MP Biomedicals Inc.
- Exhibit 157: MP Biomedicals Inc. - Overview
- Exhibit 158: MP Biomedicals Inc. - Key offerings
- 12.17 OraSure Technologies Inc.
- Exhibit 159: OraSure Technologies Inc. - Overview
- Exhibit 160: OraSure Technologies Inc. - Business segments
- Exhibit 161: OraSure Technologies Inc. - Key offerings
- Exhibit 162: OraSure Technologies Inc. - Segment focus
13 Appendix
- 13.2 Inclusions and exclusions checklist
- Exhibit 163: Inclusions checklist
- Exhibit 164: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 165: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 166: Research methodology
- Exhibit 167: Validation techniques employed for market sizing
- Exhibit 168: Information sources
- 13.5 List of abbreviations
- Exhibit 169: List of abbreviations
Get the report (PDF) sent to your email within minutes.